Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – When patients with rheumatic illnesses and concomitant diabetes are treated with hydroxychloroquine, their HbA1c levels drop significantly. Methotrexate, however, does not have the…
NEW YORK (Reuters Health) – The risk of developing post-pericardiotomy syndrome (PPS) in cardiac surgery patients can be halved by treatment with colchicine, an international team has shown.…
NEW YORK (Reuters Health) – Compared with dual therapy for HIV, highly active antiretroviral therapy (HAART) in pregnant women is associated with an increased risk of preterm delivery,…
NEW YORK (Reuters Health) – Measuring both the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) when an inflammatory condition is suspected is not helpful and is possibly…
NEW YORK (Reuters Health) – A consensus statement compiled by an international panel proposes that the level of platelet reactivity during antiplatelet therapy is a better measure of…
NEW YORK (Reuters Health) – A new study of Ethiopian communities where azithromycin was distributed widely to prevent the spread of trachoma found that macrolide resistance dropped off…
NEW YORK (Reuters Health) – Adopting a low-fat diet with a low glycemic index improves triglyceride levels and may increase insulin sensitivity in patients with impending metabolic syndrome.…
NEW YORK (Reuters Health) – As soon as 2 years after diagnosis, children and adolescents with type 2 diabetes require increasing doses of insulin — reflecting a more…
NEW YORK (Reuters Health) – Aortic root dilation is uncommon in highly trained competitive athletes and is not likely to be caused by exercise training. Consequently, aortic root…
NEW YORK (Reuters Health) – Children with overactive bladder who have not responded to behavioral therapy and treatment with oxybutynin or tolterodine may be helped by treatment with…
